# Follow-up of Ph+ Chronic Myleoid Leukemia Patients in Complete Cytogenetic Response With Interferon Based Therapy

> **NCT01490853** · — · COMPLETED · sponsor: **Università degli Studi di Brescia** · enrollment: 116 (actual)

## Conditions studied

- Chronic Myeloid Leukemia

## Interventions

- **DRUG:** Interpheron alpha

## Key facts

- **NCT ID:** NCT01490853
- **Lead sponsor:** Università degli Studi di Brescia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2012-01
- **Final completion:** 2014-12
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2018-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01490853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01490853, "Follow-up of Ph+ Chronic Myleoid Leukemia Patients in Complete Cytogenetic Response With Interferon Based Therapy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01490853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*